http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SK-3362002-A3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1bde28565d28f037e78bf4a67776ee24 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-87 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-87 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D- |
| filingDate | 2001-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1cc4ae894597063bd916d901d753bf8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7a9d0865217cfc10474bf56912d1782 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02f3fef74511a9152508471ee91d921f |
| publicationDate | 2002-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | SK-3362002-A3 |
| titleOfInvention | Method for the preparation of citalopram |
| abstract | A method for the manufacture of citalopram characterised in(i) reaction of 1-(4'-fluorophenyl)-1-(3-dimethylaminopropyl)-5-halophtalane with activated magnesium to form the Grignard reagent [3-[1-(4-fluorophenyl)-1,3 dihydro-isobenzofuran-1-yl]propyl]dimethylamine 5-magnesium halide followed by (ii) reaction of [3-[1-(4-fluorophenyl)-1,3 dihydro-isobenzofuran-1-yl]propyl]dimethylamine 5-magnesium halide with a compound containing a -CN group bound to a leaving group to form citalopram. |
| priorityDate | 2000-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 44.